英国Bestek Global Limited股权剥离及业务分离公告

公告编号：BST-WL-GD-962

发布日期：2023年12月25日

致：全体股东、债权人、合作伙伴及社会各界

本公司广东百事泰医疗器械股份有限公司（以下简称“本公司”）原为英国Bestek Global Limited公司（以下简称“目标公司”）的唯一股东，持有其100%的股权，鉴于双方业务发展的需要及战略调整，本公司特此公告如下：

一、股权剥离事宜

本公司已于2023年12月24日正式完成对目标公司的股权剥离，将所持有的目标公司全部股权转让给 LIHUA XU （以下简称“受让方”）。本次股权转让已经过相关监管机构的批准，并完成了工商变更登记，确保受让方合法取得目标公司的所有权和控制权。自此，本公司与目标公司之间的股权关系正式解除，本公司不再是目标公司的股东，也不存在任何关联关系。

二、业务分离事宜

伴随着股权剥离的完成，本公司与目标公司之间的业务关系也已实现完全分离。本公司不再参与目标公司的日常经营活动，不再授权品牌与目标公司使用，也不再对其享有或承担任何权利、义务或责任。目标公司将作为受让方的全资公司，独立开展业务，独立承担其经营行为、法律纠纷及财务状况等所有相关责任。

三、法律关系解除

本次股权剥离及业务分离完成后，本公司与目标公司之间的所有法律关系，包括但不限于股权关系、管理关系、财务关系、税务关系、品牌授权关系等，均已正式解除。今后，目标公司的任何经营行为、法律纠纷等，均与本公司无关，本公司对此不承担任何形式的责任或义务。

四、后续事宜

本公告自发布之日起生效，对本公司及目标公司均具有法律约束力。任何违反本公告条款的行为，将视为对本公司及目标公司权益的严重侵害，并可能引发相应的法律责任。

五、联系方式

如有任何关于本公告的疑问或需要进一步确认的事项，请通过以下方式联系本公司：

电子邮箱：info@bestekcorp.com  联系电话：+86-755-29977792

特此公告，望周知。

                                             广东百事泰医疗器械股份有限公司

                                                    2023年12月25日

Announcement Number: BST-WL-GD-962

Release Date: December 25, 2023

To: All Shareholders, Creditors, Partners, and the General Public

Our company, Guangdong Bestek Medical Device Co., Ltd. (hereinafter referred to as "the Company"), was originally the sole shareholder of Bestek Global Limited, a company based in the United Kingdom (hereinafter referred to as "the Target Company"), holding 100% of its equity. In consideration of the business development needs and strategic adjustments of both parties, the Company hereby announces as follows:

I. Equity Divestiture Matters

The Company has officially completed the equity divestiture of the Target Company on December 24, 2023, transferring all of its equity holdings in the Target Company to LIHUA XU (hereinafter referred to as "the Transferee"). This equity transfer has been approved by the relevant regulatory authorities and the industrial and commercial change registration has been completed, ensuring that the Transferee has legally obtained the ownership and control of the Target Company. As of this point, the equity relationship between the Company and the Target Company has been officially terminated. The Company is no longer a shareholder of the Target Company and there are no associated relationships between the two.

II. Business Separation Matters

With the completion of the equity divestiture, the business relationship between the company and the target company has also been fully severed. The company no longer participates in the daily operations of the target company, nor does it authorize the use of its brand by the target company. Furthermore, we no longer hold or assume any rights, obligations, or responsibilities towards the target company. The target company, as a wholly-owned subsidiary of the transferee, will conduct its business independently and bear all related responsibilities for its operational actions, legal disputes, and financial status.

III. Termination of Legal Relationships

Upon the completion of this equity divestiture and business separation, all legal relationships between the company and the target company, including but not limited to equity relationships, management relationships, financial relationships, tax relationships, and brand licensing relationships, have been formally terminated. Henceforth, any business activities or legal disputes involving the target company shall have no connection with the company, and the company shall bear no responsibilities or obligations of any kind in this regard.

IV. Subsequent Matters

This announcement shall take effect from the date of its issuance and shall have legal binding force on both the Company and the Target Company. Any actions that violate the terms of this announcement shall be deemed as a serious infringement of the rights and interests of the Company and the Target Company, and may trigger corresponding legal liabilities.

V. Contact Information

For any inquiries or further clarification regarding this announcement, please contact the Company through the following channels:

Email: info@bestekcorp.com
Tel: +86-755-29977792

This announcement is hereby made for general information. Thank you for your attention.

广东百事泰医疗器械股份有限公司

Guangdong BESTEK Medical Devices Co.,Ltd

                                                    December 25, 2023